Mark Neumann

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Michael Greco, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Neumann:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Common Stock 0 $0 $132.00 02 Apr 2025 Direct
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Performance Stock Units 0 $0 $132.00 02 Apr 2025 Direct
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Restricted Stock Units 0 $0 $132.00 02 Apr 2025 Direct
Veradermics, Inc Chief Commercial Officer, Strategy Officer Stock Option (Right to Buy) 102,885 03 Feb 2026 Direct
Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Stock Option (right to buy) 0 02 Apr 2025 Direct

Insider Reports Filed by Mark Neumann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MANE Veradermics, Inc 03 Feb 2026 1 $0 4 Chief Commercial Officer, Strategy Officer 05 Feb 2026, 19:02
MANE Veradermics, Inc 03 Feb 2026 0 $0 3 Chief Commercial Officer, Strategy Officer 03 Feb 2026, 21:05
ITCI Intra-Cellular Therapies, Inc. 02 Apr 2025 9 -$6,971,052 4 EVP, Chief Commercial Officer 02 Apr 2025, 17:41
ITCI Intra-Cellular Therapies, Inc. 06 Mar 2025 6 -$1,139,935 4 EVP, Chief Commercial Officer 10 Mar 2025, 18:01
ITCI Intra-Cellular Therapies, Inc. 01 Mar 2025 3 -$475,494 4 EVP, Chief Commercial Officer 04 Mar 2025, 18:01
ITCI Intra-Cellular Therapies, Inc. 31 Jan 2025 3 -$600,583 4 EVP, Chief Commercial Officer 04 Feb 2025, 17:31
ITCI Intra-Cellular Therapies, Inc. 16 Aug 2024 3 -$714,688 4 EVP, Chief Commercial Officer 20 Aug 2024, 18:03
ITCI Intra-Cellular Therapies, Inc. 07 Mar 2024 7 -$1,356,110 4 EVP, Chief Commercial Officer 11 Mar 2024, 20:31
ITCI Intra-Cellular Therapies, Inc. 06 Mar 2024 2 $0 4 EVP, Chief Commercial Officer 08 Mar 2024, 17:59
ITCI Intra-Cellular Therapies, Inc. 01 Mar 2024 1 $0 4 EVP, Chief Commercial Officer 05 Mar 2024, 19:05
ITCI Intra-Cellular Therapies, Inc. 23 Feb 2024 6 -$554,491 4 EVP, Chief Commercial Officer 27 Feb 2024, 19:58
ITCI Intra-Cellular Therapies, Inc. 01 Feb 2024 3 -$796,367 4 EVP, Chief Commercial Officer 05 Feb 2024, 18:07
ITCI Intra-Cellular Therapies, Inc. 06 Nov 2023 4 -$1,717,661 4 EVP, Chief Commercial Officer 08 Nov 2023, 17:31
ITCI Intra-Cellular Therapies, Inc. 07 Aug 2023 3 -$2,223,060 4 EVP, Chief Commercial Officer 09 Aug 2023, 18:05
ITCI Intra-Cellular Therapies, Inc. 28 Mar 2023 2 -$847,380 4 EVP, Chief Commercial Officer 30 Mar 2023, 17:08
ITCI Intra-Cellular Therapies, Inc. 09 Mar 2023 7 -$539,599 4 EVP, Chief Commercial Officer 13 Mar 2023, 19:35
ITCI Intra-Cellular Therapies, Inc. 06 Mar 2023 1 $0 4 EVP, Chief Commercial Officer 08 Mar 2023, 18:52
ITCI Intra-Cellular Therapies, Inc. 01 Mar 2023 1 -$362,122 4 EVP, Chief Commercial Officer 03 Mar 2023, 18:03
ITCI Intra-Cellular Therapies, Inc. 23 Feb 2023 3 -$190,648 4 EVP, Chief Commercial Officer 27 Feb 2023, 19:03
ITCI Intra-Cellular Therapies, Inc. 18 Feb 2023 5 -$183,246 4 EVP, Chief Commercial Officer 22 Feb 2023, 19:05
ITCI Intra-Cellular Therapies, Inc. 08 Apr 2022 5 -$4,458,841 4 EVP, Chief Commercial Officer 08 Apr 2022, 18:56
ITCI Intra-Cellular Therapies, Inc. 10 Mar 2022 2 $0 4 EVP, Chief Commercial Officer 14 Mar 2022, 16:13
ITCI Intra-Cellular Therapies, Inc. 23 Feb 2022 5 -$412,810 4 EVP, Chief Commercial Officer 25 Feb 2022, 18:08
ITCI Intra-Cellular Therapies, Inc. 18 Feb 2022 4 -$615,827 4 EVP, Chief Commercial Officer 23 Feb 2022, 18:07
ITCI Intra-Cellular Therapies, Inc. 08 Jan 2022 5 -$854,255 4 EVP, Chief Commercial Officer 11 Jan 2022, 19:06
ITCI Intra-Cellular Therapies, Inc. 15 Oct 2021 6 -$549,551 4 EVP, Chief Commercial Officer 19 Oct 2021, 16:26